For: | Lynch EN, Campani C, Innocenti T, Dragoni G, Biagini MR, Forte P, Galli A. Understanding fatigue in primary biliary cholangitis: From pathophysiology to treatment perspectives. World J Hepatol 2022; 14(6): 1111-1119 [PMID: PMC9258253 DOI: 10.4254/wjh.v14.i6.1111] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v14/i6/1111.htm |
Number | Citing Articles |
1 |
Anne Toussaint, Angelika Weigel, Bernd Löwe, Jordi Blanch, Katleen Bogaerts, Birgitte Boye, Chris Burton, Fiammetta Cosci, Petra Engelmann, Per Fink, Susanne Fischer, Stephan Frisch, Lisbeth Frostholm, Lise Kirstine Gormsen, Monica Greco, Karen Hansen Kallesoe, Tim olde Hartman, Tanja Hechler, Severin Hennemann, Peter Henningsen, Katharina Hüfner, Paul Hüsing, Joram Ronel, Roland von Känel, Christopher A. Kenedi, Ferenc Köteles, Sebastian Kohlmann, Willem J. Kop, Nadine Lehnen, James Levenson, Bernd Löwe, Kerstin Maehder, Alexandra Martin, Christoph Pieh, Victor Pitron, Charlotte Ulrikka Rask, Winfried Rief, Marianne Rosendal, Judith Rosmalen, Joanna Rymaszewska, Markku Sainio, Stefan Salzmann, Rainer Schaefert, Sanna Selinheimo, Meike Shedden-Mora, Jon Stone, Lineke Tak, Anne Toussaint, Natalie Uhlenbusch, Omer Van den Bergh, Lars de Vroege, Angelika Weigel, Ursula Werneke, Michael Witthöft. The overlooked burden of persistent physical symptoms: a call for action in European healthcare. The Lancet Regional Health - Europe 2025; 48: 101140 doi: 10.1016/j.lanepe.2024.101140
|
2 |
Zobair M. Younossi, Andreas E. Kremer, Mark G. Swain, David Jones, Christopher Bowlus, Michael Trauner, Linda Henry, Lynn Gerber. Assessment of fatigue and its impact in chronic liver disease. Journal of Hepatology 2024; 81(4): 726 doi: 10.1016/j.jhep.2024.04.008
|
3 |
Atsushi Tanaka. New Therapies on the Horizon for Primary Biliary Cholangitis. Drugs 2024; 84(1): 1 doi: 10.1007/s40265-023-01979-1
|
4 |
Atsushi Tanaka, Xiong Ma, Atsushi Takahashi, John M Vierling. Primary biliary cholangitis. The Lancet 2024; 404(10457): 1053 doi: 10.1016/S0140-6736(24)01303-5
|
5 |
Kathryn Jack, Palle Bager. Research round-up. Gastrointestinal Nursing 2023; 21(Sup1): S6 doi: 10.12968/gasn.2023.21.Sup1.S6
|
6 |
Asma Faisal. Understanding fatigue and pruritus in primary biliary cholangitis. Clinical Liver Disease 2024; 23(1) doi: 10.1097/CLD.0000000000000216
|
7 |
Palle Bager, Lars Bossen, Rasmus Gantzel, Henning Grønbæk, Wan-Long Chuang. High-dose oral thiamine versus placebo for chronic fatigue in patients with primary biliary cholangitis: A crossover randomized clinical trial. PLOS ONE 2024; 19(3): e0301354 doi: 10.1371/journal.pone.0301354
|
8 |
Ju Zou, Jie Li, Xiaoxu Wang, Daolin Tang, Ruochan Chen. Neuroimmune modulation in liver pathophysiology. Journal of Neuroinflammation 2024; 21(1) doi: 10.1186/s12974-024-03181-w
|
9 |
Louisa Stern, Constantin Schmidt, Lorenz Kocheise, Vincent Joerg, Christian Casar, Aurélie Walter, Joost P.H. Drenth, Maria Papp, Nikolaos K. Gatselis, Kalliopi Zachou, Matthias Pinter, Bernhard Scheiner, Arndt Vogel, Martha M. Kirstein, Fabian Finkelmeier, Oliver Waidmann, Arndt Weinmann, Piotr Milkiewicz, Douglas Thorburn, Neil Halliday, Ana Lleo, Samuel Huber, George N. Dalekos, Ansgar W. Lohse, Henning Wege, Johann von Felden, Kornelius Schulze. Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinoma. Annals of Hepatology 2024; 29(6): 101534 doi: 10.1016/j.aohep.2024.101534
|
10 |
Mariana Zapata, Hendrick Pagan-Torres, Marlyn J. Mayo. Systemic Complications of Primary Biliary Cholangitis. Clinics in Liver Disease 2024; 28(1): 115 doi: 10.1016/j.cld.2023.07.004
|
11 |
Torbjörn Bäckström, Magnus Doverskog, Thomas P. Blackburn, Bruce F. Scharschmidt, Vicente Felipo. Allopregnanolone and its antagonist modulate neuroinflammation and neurological impairment. Neuroscience & Biobehavioral Reviews 2024; 161: 105668 doi: 10.1016/j.neubiorev.2024.105668
|